SAN JOSE, Calif and WAKEFIELD, Mass. – RAE Systems Inc. (AMEX: RAE ), a leading global provider of rapidly deployable sensor networks that enable customers to identify safety and security threats in real time, and Implant Sciences Corporation (AMEX: IMX), a developer and manufacturer of products for national security, medicine and industry, today announced RAE Systems has signed an agreement with Implant Sciences to explore the deployment of Implant Science’s QS-H150 Portable Explosives Trace Detector into AreaRAE wireless sensor networks.
“Homeland security customers worldwide are continually looking for more sensitive and non-invasive explosive detection solutions. This partnership with Implant Sciences expands RAE Systems’ open wireless network strategy for meeting the Chemical, Biological, Radiation, Nuclear and Explosive (CBRNE) detection needs of first responders for public venue protection,” said Robert Chen, chief executive officer for RAE Systems. “The QS-H150 Portable Explosives Trace Detector is capable of detecting trace amounts of most commercial and military explosives, including RDX, PETN, HMX, TNT, Black Powder and Ammonium Nitrate at nanogram level concentrations in real time.”
“The demand for trace detection equipment is growing worldwide,” said Dr. Anthony J. Armini, PhD., CEO of Implant Sciences. “We see this partnership with RAE Systems as an opportunity to equip first responders with next generation detection technology that can provide real-time information to incident commanders in a variety of high security environments.”
Implant Sciences’ proprietary Quantum SnifferTM technology and products are differentiated from competitors. The company’s products detect a wide array of explosives using a proprietary non-contact vortex sampling system. Further, the equipment does not require a radioactive source and has extremely low operating costs. The Quantum Sniffer has been sold worldwide for use by first responders, such as local law enforcement, maritime security, air and ground transportation logistics, aviation security, private and government infrastructure security, and cargo delivery. For more information on the QS-H150 please go to www.implantsciences.com .
For more information on the RAE Systems family of AreaRAE wireless sensor solutions please go to www.raesystems.com .
About RAE Systems
RAE Systems is a leading global provider of rapidly deployable sensor networks that enable customers to identify safety and security threats in real time. Products include multi-sensor chemical detection , wireless gas diction , radiation and digital video monitoring networks for homeland security and industrial applications. RAE Systems’ products enable the military and first responders such as firefighters, law enforcement and other emergency management personnel to detect, provide early warning and record events that involve weapons of mass destruction and other hazardous materials. Industrial applications include the detection of toxic industrial chemicals, volatile organic compounds and petrochemicals . RAE Systems’ products are used by many U.S. government agencies, including the Department of Homeland Security, the Department of Justice, and the Department of State, as well as all branches of the U.S. military, and by numerous city and state agencies. Our end users also include many of the world’s leading corporations in the airline, automotive, computer and oil industries. Our products are used in civilian and government atmospheric monitoring programs in over 50 countries . For more information about RAE Systems, please visit www.RAESystems.com .
About Implant Sciences
Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for the homeland security, semiconductor and medical device industries. The Company has developed and commercialized portable and bench-top detection devices to identify explosives which are distributed under the Quantum Sniffer(TM) brand name. The Company also provides state of the art ion implantation and wafer analytical services for the semiconductor industry. The Company also develops, manufactures and sells radioactive products for the treatment of cancer, including sales of radioactive seeds for the treatment of prostate cancer and development of a new, FDA approved radioactive source for use in the treatment of breast cancer. For further details on the Company and its products please visit the Company’s website at www.implantsciences.com .
Safe Harbor Statement
This press release may contain “forward-looking” statements, as that term is used in Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include, without limitation: expressions of “belief,” “anticipation,” or “expectations” of management; statements as to industry trends or future results of operations of RAE Systems and its subsidiaries; and other statements that are not historical fact. These types of statements address matters that are subject to risks and uncertainties, which could cause actual results to differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the general economic and industry factors and receptiveness of the market to RAE Systems and its products. In addition, our forward-looking statements should be considered in the context of other risk factors discussed in our filings with the Securities and Exchange Commission, including but not limited to our annual report on Form 10-K and Form 10-Q filings, available online at http://www.sec.gov. All forward-looking statements are based on information available to the Company on the date hereof, and the Company assumes no obligation to update such statements.